| scholarly article | Q13442814 |
| P50 | author | Adnan Sharif | Q38329268 |
| Nada Alachkar | Q64269802 | ||
| P2093 | author name string | E Kraus | |
| P2860 | cites work | The proteasome inhibitor bortezomib enhances the susceptibility to viral infection | Q28261854 |
| Incompatible live-donor kidney transplantation in the United States: results of a national survey | Q28741418 | ||
| Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies | Q34205519 | ||
| Accommodation in renal transplantation: unanswered questions | Q34903473 | ||
| Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin | Q35664634 | ||
| Infectious risks and optimal strength of maintenance immunosuppressants in rituximab-treated kidney transplantation | Q35953320 | ||
| Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients | Q36126901 | ||
| The IL-6/sIL-6R complex as a novel target for therapeutic approaches | Q36804420 | ||
| Antibody-mediated rejection in renal allografts: lessons from pathology | Q36910391 | ||
| Banff 2011 Meeting report: new concepts in antibody-mediated rejection | Q37058043 | ||
| Transplant glomerulopathy | Q37092282 | ||
| ABO incompatible renal transplantation: a paradigm ready for broad implementation | Q37454277 | ||
| The significance of C4d staining with minimal histologic abnormalities | Q37631388 | ||
| Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols | Q37685188 | ||
| Sensitized renal transplant recipients: current protocols and future directions | Q37710374 | ||
| Rituximab-associated infections | Q37720889 | ||
| Rejection of the kidney allograft | Q37798268 | ||
| Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients | Q37827197 | ||
| Desensitization protocols and their outcome | Q37858260 | ||
| Quantifying HLA-specific antibodies in patients undergoing desensitization | Q37888424 | ||
| B-cell immunotherapeutics: emerging roles in solid organ transplantation | Q37888431 | ||
| Targeting B cells and antibody in transplantation | Q37888770 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| In vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartment | Q42689640 | ||
| Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation | Q43181339 | ||
| Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejection | Q43222014 | ||
| Antibody removal before ABO-incompatible renal transplantation: how much plasma exchange is therapeutic? | Q43524187 | ||
| The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction | Q44135123 | ||
| Positive cross-match living donor kidney transplantation: longer-term outcomes | Q46134337 | ||
| Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience | Q46155740 | ||
| Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch. | Q46505754 | ||
| Significance of the positive crossmatch test in kidney transplantation | Q47800073 | ||
| ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation. | Q50579449 | ||
| Desensitization in HLA-incompatible kidney recipients and survival. | Q51018759 | ||
| Kidney paired donation and optimizing the use of live donor organs. | Q51975686 | ||
| Postischemic inflammatory response in an auxiliary liver graft predicts renal graft outcome in sensitized patients. | Q54377841 | ||
| Successful Combined Partial Auxiliary Liver and Kidney Transplantation in Highly Sensitized Cross-Match Positive Recipients | Q59257891 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney transplantation | Q740909 |
| P304 | page(s) | 1141-1150 | |
| P577 | publication date | 2012-08-20 | |
| P1433 | published in | QJM: An International Journal of Medicine | Q7265477 |
| P1476 | title | Incompatible kidney transplantation: a brief overview of the past, present and future | |
| P478 | volume | 105 |
| Q38151236 | Allocation and matching in kidney exchange programs |
| Q38972358 | Evolution of Renal Transplant Practice Over the Past Decade: A U.K. Center Experience |
| Q38246582 | Humoral immunity and complement effector mechanisms after lung transplantation |
| Q35715908 | Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation |
| Q28081350 | Polyomaviruses and disease: is there more to know than viremia and viruria? |
Search more.